Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

Todd Meyer, PhD, Theresa Robson, B.S., Ali Amirkhosravi, Ph.D., Florian Langer, M.D., Hina Desai, M.S., Mildred Amaya, M.S., Pierre Elias, John L. Francis, Ph.D.

Blood (2006) 108 (11): 1091.

https://doi.org/10.1182/blood.V108.11.1091.1091

Published: 2006

Journal Articles

Blood-Borne, but Not Endothelial CD40 Promotes Experimental Lung Metastasis.

Ali Amirkhosravi, PhD, Susan B. Ingersoll, Ph.D., Theresa Robson, BS, Florian Langer, M.D., Jamie Walker, BS, John L. Francis, Ph.D.

Blood (2006) 108 (11): 1092.

https://doi.org/10.1182/blood.V108.11.1092.1092

Published: 2006

Journal Articles

Hypercoagulability in Ovarian Cancer Revisited: A Prospective Analysis of Coagulation and Platelet Activation Markers.

Ali Amirkhosravi, PhD, Glenn Bigsby, IV, D.O., Hina Desai, M.S., Mildred Amaya, M.S., Enriqueta Coll, Ph.D., Liza Robles, M.S., Patricia Faust, R.N., Florian Langer, M.D., Alane Drexler, R.N., Edward Reyes, M.S., John L. Francis, Ph.D.

Blood (2006) 108 (11): 1762.

https://doi.org/10.1182/blood.V108.11.1762.1762

Published: 2006

Journal Articles

Platelet Activation by a Humanized Monoclonal CD40 Ligand (CD40L) Antibody.

Todd Meyer, PhD, Ali Amirkhosravi, Ph.D., Theresa Robson, B.A., Mildred Amaya, M.S., Desai Hina, M.S., Lihe Su, Ph.D., Yen-Ming Hsu, Ph.D., Florian Langer, M.D., John L. Francis, Ph.D.

Blood (2006) 108 (11): 1516.

https://doi.org/10.1182/blood.V108.11.1516.1516

Published: 2006

Journal Articles

Genetic Evidence That CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia.

Susan B. Ingersoll, Ph.D., Ali Amirkhosravi, Ph.D., Florian Langer, M.D., Jamie Walker, Todd Meyer, Ph.D., Mildred Amaya, John L. Francis, Ph.D.

Blood (2004) 104 (11): 2975.

https://doi.org/10.1182/blood.V104.11.2975.2975

Published: 2004

NARROW

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

Blood-Borne, but Not Endothelial CD40 Promotes Experimental Lung Metastasis.

Hypercoagulability in Ovarian Cancer Revisited: A Prospective Analysis of Coagulation and Platelet Activation Markers.

Platelet Activation by a Humanized Monoclonal CD40 Ligand (CD40L) Antibody.

Genetic Evidence That CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia.

Email alerts

ASH Publications

American Society of Hematology

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

Blood-Borne, but Not Endothelial CD40 Promotes Experimental Lung Metastasis.

Hypercoagulability in Ovarian Cancer Revisited: A Prospective Analysis of Coagulation and Platelet Activation Markers.

Platelet Activation by a Humanized Monoclonal CD40 Ligand (CD40L) Antibody.

Genetic Evidence That CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only